Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05142189
What this trial is testing

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BioNTech SE 320
Testing effectiveness (Phase 2)Ended earlyNCT02147990
What this trial is testing

Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Clovis Oncology, Inc. 318
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Testing effectiveness (Phase 2)Study completedNCT00240682
What this trial is testing

Study of Cetuximab in Squamous Cell Carcinoma of the Skin Expressing EGFR

Who this might be right for
Skin DiseasesCarcinoma, Squamous Cell
Centre Hospitalier of Chartres 37
Testing effectiveness (Phase 2)Study completedNCT00563680
What this trial is testing

QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors

Who this might be right for
Askin's TumorsDesmoplastic Small Round Cell TumorsEstraosseous Ewing's Tumor+4 more
NantCell, Inc. 38
Early research (Phase 1)Study completedNCT02221882
What this trial is testing

LY3164530 in Participants With Cancer

Who this might be right for
NeoplasmsNeoplasm Metastasis
Eli Lilly and Company 29
Not applicableStudy completedNCT04767750
What this trial is testing

Role of LncRNA H19 in The Regulation of IGF-1R Expression

Who this might be right for
Hepatocellular CarcinomaType 2 DiabetesCancer
Mansoura University 101
Large-scale testing (Phase 3)Study completedNCT01901146
What this trial is testing

Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer

Who this might be right for
Breast Cancer
Amgen 725
Testing effectiveness (Phase 2)Study completedNCT00317720
What this trial is testing

Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer

Who this might be right for
Breast CancerNeoplasm Metastasis
M.D. Anderson Cancer Center 40
Post-approval studies (Phase 4)Study completedNCT02514174
What this trial is testing

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Who this might be right for
Carcinoma, Non-Small-Cell LungErbB Receptors
Boehringer Ingelheim 25
Testing effectiveness (Phase 2)Study completedNCT01832259
What this trial is testing

VEGF Tyrosine Kinase Inhibitor (Pazopanib) in Men With High-Risk Prostate Cancer Followed by Radical Prostatectomy and Pelvic Lymph Node Dissection

Who this might be right for
Adenocarcinoma of the Prostate
University of Utah 30
Large-scale testing (Phase 3)Study completedNCT01024413
What this trial is testing

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

Who this might be right for
Thoracic Neoplasms
Chinese Society of Lung Cancer 256
Not applicableLooking for participantsNCT07179926
What this trial is testing

Effects of Pasireotide Lar Therapy on Bone Metabolism

Who this might be right for
Acromegaly Due to Pituitary AdenomaAcromegaly
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Not applicableStudy completedNCT00006435
What this trial is testing

Study of Plexiform Neurofibromas in Neurofibromatosis Type 1

Who this might be right for
Plexiform NeurofibromasNF1
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT00973557
What this trial is testing

The Effect of Monoclonal Vascular Endothelial Growth Factor (VEGF) Antibody (Bevacizumab) on Pituitary Function

Who this might be right for
Colorectal CancerLung CancerBreast Cancer+1 more
Cedars-Sinai Medical Center 6
Large-scale testing (Phase 3)Study completedNCT02131064
What this trial is testing

A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Who this might be right for
Breast Neoplasms
Hoffmann-La Roche 444
Large-scale testing (Phase 3)Active Not RecruitingNCT03529110
What this trial is testing

DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]

Who this might be right for
Breast Cancer
Daiichi Sankyo 524
Large-scale testing (Phase 3)Study completedNCT01964391
What this trial is testing

Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 174
Very early researchStudy completedNCT02534376
What this trial is testing

Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal

Who this might be right for
Prostate Cancer
Cedars-Sinai Medical Center 63
Large-scale testing (Phase 3)Looking for participantsNCT05212454
What this trial is testing

Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks

Who this might be right for
Breast CancerChemotherapy Effect
Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Next Page